Carl Washington v. CVS Pharmacy Inc.
Opinion
trial_court Opinion
1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 7 CHRISTOPHER CORCORAN, ET AL., Case No. 15-cv-03504-YGR
8 Plaintiffs, ORDER (1) GRANTING AMENDED MOTION
TO SUBSTITUTE CLASS REPRESENTATIVES
9 v. AND FOR CERTIFICATION OF NEW YORK
AND ARIZONA CLASSES, AND (2) GRANTING
10 CVS HEALTH, ET AL., IN PART AND DENYING IN PART MOTION
FOR APPROVAL OF NOTICE PROVIDER AND
11 Defendants. CLASS NOTICE PROGRAM Re: Dkt. Nos. 376, 377, 386-2 12
Plaintiffs bring this putative class action against defendants alleging that they knowingly 13 overcharged millions of insured patients by submitting falsely inflated drug prices to pharmacy 14 benefit managers (“PBMs”) and third-party payor insurance providers (“TPPs”), which resulted in 15 higher copayment obligations for plaintiffs. Specifically, plaintiffs raise claims under the laws of 16 eleven states: (i) each state’s statutory laws proscribing unfair and deceptive acts and practices 17 (“UDAP”); and common law claims for (ii) fraud, (iii) negligent misrepresentation, and (iv)…